Can Fite Biopharma News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.01.18	The Race To Find A Treatment For NASH (RTTNews)
08.01.18	Can-Fite Signs Multi-Million Dollar Distribution Agreement for Piclidenoson in 3 European Countries with Gebro Holdings (Businesswire)
21.12.17	SS&C GlobeOp Forward Redemption Indicator: December notifications 4.18% (PR Newswire)
22.11.17	Eisai Announces Presentations on Perampanel (marketed as FYCOMPA CIII) at the Annual Meeting of the American Epilepsy Society (AES) (PR Newswire)
23.08.17	Judith A. Crouch is recognized by Continental Who's Who (PR Newswire)
15.06.17	Can-Fite to Participate in Bio International Convention in San Diego on June 19-22, 2017 (PR Newswire)
08.06.17	Can-Fite Concludes Successful Clinical Investigator Meeting for its ACRobat Phase III Trial of Piclidenoson in the Treatment of Rheumatoid Arthritis (PR Newswire)
01.06.17	New Preclinical Data on Can-Fite's Namodenoson to be Presented at 1st International Conference on Fatty Liver in Seville, Spain on June 2, 2017 (PR Newswire)
30.05.17	Can-Fite Reports First Quarter 2017 Financial Results & Provides Clinical Update (PR Newswire)
03.05.17	Can-Fite's Liver Protective Drug Namodenoson Enters Phase II Trial for Treatment of NAFLD/NASH (PR Newswire)
25.04.17	Can-Fite's Phase III ACRobat Trial in Rheumatoid Arthritis Approved by Institutional Review Board (PR Newswire)
31.03.17	Can-Fite Reports 2016 Financial Results & Provides Clinical Update (PR Newswire)
28.02.17	New Preclinical Data Show Can-Fite's Namodenoson (CF102) Prevents Progression of Liver Fibrosis (PR Newswire)
08.02.17	Can-Fite Gears Up for ACRobat, its Phase III Trial of Piclidenoson in Rheumatoid Arthritis (PR Newswire)
19.01.17	Can-Fite BioPharma Announces $5 Million Registered Direct Offering (PR Newswire)
09.01.17	Can-Fite Receives IRB Approval to Commence Patient Enrollment in Phase II NAFLD/NASH Trial in Q1 2017 (PR Newswire)
30.05.16	AZN's Falcon Hits Goal, FDA Approves MS Drug, CANF Awaits Data In June (RTTNews)
20.09.15	Can-Fite BioPharma Announces $9 Mln Registered Direct Offering - Quick Facts (RTTNews)
18.09.15	CANF Making Big Move, TGTX And FDA On The Same Page For CLL Trial, APRI On Watch (RTTNews)
17.09.15	FDA Grants Fast Track Designation To Can-Fite'CF102 In Treatment Of Liver Cancer (RTTNews)
05.02.15	DPLO To Dispense Breast Cancer Drug, New Use For Old Drugs Sought, CANF On Watch (RTTNews)
28.01.15	ABMD Posts Stellar Results, HNSN Rallies, STJ Gets FDA Nod, Watch Out For VBLT (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Lonza Grp	611.60	2.34 %	K V
CieFinRichemont	176.70	0.54 %	K V
Logitech Intl	88.92	0.34 %	K V
Zurich Insur Gr	555.00	0.33 %	K V
Givaudan	3’935.00	0.25 %	K V
Kuehne+Nagel Int	202.00	-0.59 %	K V
Swisscom	506.50	-0.69 %	K V
Nestle	77.22	-0.82 %	K V
Sonova Hldg	308.40	-2.41 %	K V
UBS Group	29.88	-6.01 %	K V

Nachrichten zu Can Fite Biopharma Ltd (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten